
Grove Biopharma
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
If it were possible to watch drugs molecules at work under a microscope — seeing precisely how they act on different proteins inside cells — it would revolutionize drug development. Micrographia is doing just that. The company uses machine learning to analyze microscopy images at high throughput, allowing researchers and drug developers to unravel disease mechanisms at the subcellular level.
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Programming stem cells to differentiate into desired cell types, faster
Using state-of-the-art machine learning models to create custom-build protein drugs
Mapping the brain-body axis to achieve proper immune balance